R
RVMD
Revolution Medicines, Inc. Common Stock
$193.52
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Revolution Medicines, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$4.80
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
After the close · Expected EPS: -$2.46
Nov 11
Posts
No posts about RVMD yet.
About Revolution Medicines, Inc. Common Stock
Revolution Medicines is a clinical-stage cancer drug developer. It builds pills that shut down RAS proteins, a family of cancer-driving switches found in many pancreatic, lung and colorectal tumors. The company has no approved product and no sales, so it pays its bills with cash raised from investors and with collaboration funding.